Cargando…
Proteome profiling reveals novel biomarkers to identify complicated parapneumonic effusions
Patients with pneumonia and parapneumonic effusion (PPE) have elevated mortality and a poor prognosis. The aim of this study was to discover novel biomarkers to help distinguish between uncomplicated PPE (UPPE) and complicated PPE (CPPE). Using an iTRAQ-based quantitative proteomics, we identified 7...
Autores principales: | Wu, Kuo-An, Wu, Chih-Ching, Chen, Chi-De, Chu, Chi-Ming, Shih, Li-Jane, Liu, Yu-Ching, Wang, Chih-Liang, Lin, Hsi-Hsien, Yang, Chia-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481374/ https://www.ncbi.nlm.nih.gov/pubmed/28642494 http://dx.doi.org/10.1038/s41598-017-04189-4 |
Ejemplares similares
-
Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema
por: Wu, Kuo-An, et al.
Publicado: (2019) -
Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema
por: Yang, Chia-Yu, et al.
Publicado: (2021) -
Serum and Pleural Fluid Procalcitonin in Predicting Bacterial Infection in Patients with Parapneumonic Effusion
por: Ko, Yang-Ching, et al.
Publicado: (2009) -
A study of the proteomic expression in patients with complicated parapneumonic pleural effusion
por: Wu, Xin, et al.
Publicado: (2021) -
Treatment of complicated parapneumonic pleural effusion and pleural parapneumonic empyema
por: Suárez, Pedro Rodríguez, et al.
Publicado: (2012)